ATP stimulates MDM2-mediated inhibition of the DNA-binding function of E2F1

Craig Stevens1, Susanne Pettersson, Bartosz Wawrzynow

  • 1Cell Signaling Unit, University of Edinburgh, UK.

The FEBS Journal
|August 30, 2008
PubMed

Insights

Murine double minute 2 (MDM2) protein

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Protein Folding

Background:

  • Murine double minute 2 (MDM2) protein regulates tumor suppressor p53 via transcriptional suppression and E3 ubiquitin ligase activity.
  • Emerging evidence indicates MDM2 possesses ATP-dependent molecular chaperone activity, influencing p53 tetramer folding.

Purpose of the Study:

  • To investigate the ATP-dependent molecular chaperone function of MDM2 on its target protein, transcription factor E2F1.
  • To elucidate the role of MDM2's ATP-binding domain in regulating protein-protein interactions and substrate protein folding.

Main Methods:

  • Established a system to analyze MDM2's chaperone function on E2F1.
  • Utilized ATP and ATP-binding domain mutants (K454A) of MDM2.
  • Employed antibodies against MDM2 domains and dimethylsulfoxide (DMSO).

Main Results:

  • MDM2 inhibited E2F1 DNA-binding activity in an ATP-dependent manner.
  • ATP stabilized E2F1:MDM2 binding, while destabilizing MDM2:p53 complex.
  • ATP-binding mutant MDM2 retained E3 ubiquitin ligase activity, but lost ATP-stimulated E2F1 inhibition.
  • Multiple MDM2 domains and reduced protein unfolding (via DMSO) were crucial for E2F1 inhibition.

Conclusions:

  • The ATP-binding domain of MDM2 specifically modulates its protein-protein interaction function, influencing substrate protein folding.
  • MDM2's chaperone activity on E2F1 is distinct from its E3 ligase activity and is regulated by ATP.
  • These findings offer novel insights into MDM2's diverse functions and evolutionary trajectory.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...